Stockreport

Nemaura Medical Provides Update Regarding Commercial Launch of SugarBEAT® and First Patient User Experiences as Presented at EASD Symposia 2019 in Barcelona

Nemaura Medical, Inc.  (NMRD) 
NASDAQ:AMEX Investor Relations: nemauramedical.com/investors
PDF Loughborough, England, Oct. 03, 2019 (GLOBE NEWSWIRE) --  Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercializati [Read more]